amifostine anhydrous has been researched along with Adenoma in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Adenoma: A benign epithelial tumor with a glandular organization.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glover, DJ | 1 |
| Shaw, L | 1 |
| Glick, JH | 1 |
| Slatopolsky, E | 1 |
| Weiler, C | 1 |
| Attie, M | 1 |
| Goldfarb, S | 1 |
1 other study available for amifostine anhydrous and Adenoma
| Article | Year |
|---|---|
Treatment of hypercalcemia in parathyroid cancer with WR-2721, S-2-(3-aminopropylamino)ethyl-phosphorothioic acid.
Topics: Adenoma; Aged; Amifostine; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; H | 1985 |